期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

不同剂量氟伐他汀对冠状动脉粥样硬化性心脏病颈动脉粥样硬化的影响

下载PDF
导出
作者 石建平 张凯 王泰然 赵梦华 张海燕
机构地区 河北省邯郸市中心医院心内科
出处 《河北中医》 2009年第9期1428-1429,共2页 Hebei Journal of Traditional Chinese Medicine
关键词 超声检查 多普勒 彩色 动脉硬化 冠状动脉疾病 颈动脉疾病 C反应蛋白质 脂类
分类号 R543.305 [医药卫生—心血管疾病] R972.6 [医药卫生—药品]
  • 相关文献

参考文献10

  • 1高润霖,吴宁,胡大一,等.心血管病治疗指南和建议[M].北京:人民军医出版社,2005:158.
  • 2Ghiadoni L,Taddei S,Virdis A,et al.Endothelial function and common carotid artery wall thickening in patients with essential hypertension[J].Hypertension,1998,32(1):25-32.
  • 3王海艳,郝玉明,李涛,崔炜,刘凡,谢文丽,郑红梅.冠心病患者周围动脉内膜-中层厚度的研究[J].中国心血管杂志,2004,9(4):282-282. 被引量：12
  • 4Yamasaki Y,Kodama M,Nishizawa H,et al.Carotid intima-media thickness in Japanese type-2 diabetic subjects:predictors of progression and relationship with incident coronary heart disease[J].Diabetes Care,2000,23(9):1310-1315.
  • 5涂燕平,龚爱斌,魏伟荣,王凌玲.冠心病患者血清C反应蛋白检测的临床意义[J].临床心血管病杂志,2002,18(2):89-89. 被引量：36
  • 6O'Leary DH,Polak JF,Kronmal RA,et al.Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults[J].N Engl J Med,1999,340(1):14-22.
  • 7Sever PS,Dahlof R,Poulter NR,et al.Prevention of coronary and stroke events with atorvastatin,in hypertensive patients who have average or lower-than-average cholesterol concentrations in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm(ASCOT-LLA):a multicentre randomized controlled trial[J].Lancet,2003,361(9364):1149-1158.
  • 8Feron O,Dessy C,Desager JP,et al.Hydroxy-methylglutaryl-coenzyme areductase inhibition promotes endothelial nitric oxide synthase A ctivation through a decrease in caveolin abundance[J].Circulation,2001,103(1):113-118.
  • 9杨丽平,刘丽文,钱蕴秋,杨力军,李兰荪,何光彬,周晓东,沈敏.阿托伐他汀对冠心病患者颈动脉内-中膜厚度的影响[J].西北国防医学杂志,2007,28(2):104-106. 被引量：6
  • 10林培林,王涛,李雅男,曹广智.阿托伐他汀对高脂血症患者颈动脉内膜中层厚度及凝血系统的影响[J].高血压杂志,2004,12(1):21-23. 被引量：15

二级参考文献22

  • 1[1]Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med,1999,340:115-126.
  • 2[2]Anderson J L, Carlquist J F, Joseph B, et al. Evaluation of C-reactive protien, an inflammatory marker, and infectious serology as risk factor for coronary artery disease and myocardial infarction. JACC,1998,32:35-35.
  • 3[3]Haverkate F, Thompson S G, Pyke S D M, et al. Production of C-reactive protien and risk of coronary events in stable and unstable angina: European concerted action on thrombosis and disabilities angina pectoris study group. Lancet, 1997,349:462-462.
  • 4Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol, 1983, 51: 606-606.
  • 5Crouse JR, Harpold GH, Kahl FR, et al. Evaluation of a scoring system for carotid atherosclerosis extent with B-mode ultrasound[J]. Stroke, 1986, 17: 270-275.
  • 6Smedby O. Geometrical risk factors for atherosclerosis in the femoral artery, a longitudinal angiographic study[J]. Ann Biomed Eng, 1998, 26: 391-397.
  • 7Alfon J, Guasch JF, Berrozpe M, et al. Nitric oxide synthase Ⅱ(NOS Ⅱ) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors[J].Atherosclerosis,1999,145(2):325-331.
  • 8Gotto FM. Lipid-lowering therapy for the primary prevention of coronary heart disease[J].J Am Coll Cardiol,1999,33:2078-2082.
  • 9Knapp AC, Huang J, Starling G, et al. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death[J].Atherosclerosis,2000,152:217-227.
  • 10Undas A, Brummel KE, Musial J, et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor X Ⅲ and by enhancing factor Va inactivation[J].Circulation,2001,103:2248-2253.

共引文献186

河北中医
2009年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部